Related Experiment Video
Updated: Dec 15, 2025

11:34
Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
Published on: December 5, 2017
13.0K
Variation in pathological complete response in HER2-positive breast cancers with intrinsic subtypes assessed by PAM50
Arun Kumar Goel1, Vaishali Zamre2, Shreebha Hari3
1Department of Surgical Oncology, Max Superspecialty Hospital, W-3, Sector 1, Vaishali, Ghaziabad, UP, 201012, India. arun.goel07@gmail.com.
Breast Cancer Research and Treatment
|July 11, 2020
Abstract
No abstract available in PubMed .

